Multiple Sclerosis

1. THE 2-MINUTE PHYSIOLOGY (Rapid Pathophysiology)

• The Vascular & Immune Insult: Multiple Sclerosis (MS) is a chronic, autoimmune-mediated inflammatory disorder of the Central Nervous System (CNS) characterized by focal demyelination within the brain, spinal cord, and optic nerves. Autoreactive T-cells breach the blood-brain barrier, initiating an immunologic cascade that leads to targeted myelin sheath destruction, axonal transection, and glial scarring (plaques).
• Segmental Conduction Block: Demyelination impairs the saltatory conduction of action potentials, slowing or completely blocking neural transmission. These demyelinated axons are highly vulnerable to localized mechanical stress (yielding stretch-induced axonal firing) and are exquisitely sensitive to temperature fluctuations. A change in core body temperature as small as 1°C can completely halt conduction across partially demyelinated fibers (the Uhthoff phenomenon).
• Neuroanatomical Localization: Plaques can localize anywhere within the CNS white matter, but they have a strong predilection for specific pathways:
• Corticospinal Tracts: Manifests as upper motor neuron (UMN) weakness, spasticity, and hyperreflexia.
• Posterior Columns & Spinothalamic Tracts: Causes loss of joint proprioception/vibration and pain/temperature sensation, respectively.
• Optic Nerve & Brainstem: Drives acute optic neuritis, internuclear ophthalmoplegia (INO), and autonomic dysfunction.

2. THE BEDSIDE ACTION PLAN (Rapid ER Management)

• Airway and Ventilatory Support:
• While acute primary respiratory failure in MS is rare (indicative of acute lesions in the medullary respiratory center or high cervical cord), patients in late stages of the disease with severe bulbar dysfunction (dysarthria, dysphagia) and limb paralysis are at a catastrophic risk for aspiration, mucus plugging, and progressive ventilatory fatigue.
• Measure baseline respiratory parameters at the bedside: Forced Vital Capacity (FVC) (impending failure if <20 mL/kg), Negative Inspiratory Force (NIF) (impending failure if <-30 cm H₂O), or a single-breath count test (inability to count to 20 suggests severe respiratory insufficiency).
• Intubation and Mechanical Ventilation:
• Maintain strict aspiration precautions (utilize the Sellick maneuver during intubation due to decreased gastric motility).
• NEVER use Succinylcholine for Rapid Sequence Intubation (RSI) in patients with chronic weakness or immobility due to the severe risk of a life-threatening hyperkalemic response from upregulated extrajunctional acetylcholine receptors.
• Use Rocuronium (1.0–1.5 mg/kg IV) as the preferred paralytic agent. Note: Non-depolarizing block response can be highly variable due to denervation-induced receptor changes and reduced muscle mass.
• Hemodynamic and Temperature Optimization:
• Up to two-thirds of MS patients exhibit autonomic dysfunction; expect orthostatic hypotension and labile heart rates. Treat hypotension with careful crystalloid boluses and avoid precipitous vasoactive shifts.
• Maintain strict normothermia (36.0°C to 38.3°C): Aggressively treat any rise in core temperature. Utilize acetaminophen or cooling blankets, as minor elevations can trigger severe pseudo-exacerbations.
• Targeted Pharmacotherapy for Acute Relapse:
• Administer high-dose Methylprednisolone (500–1,000 mg IV or PO every 24 hours for 3 to 5 days). High-dose oral therapy is equally efficacious and often preferred by patients for ease of administration (instruct them to take it with food).
• GI prophylaxis and steroid tapers are unnecessary for these short, acute courses.
• Neurogenic Bladder Management:
• Patients frequently suffer from detrusor-sphincter dyssynergy leading to urinary retention. Measure post-void residual (PVR) volume via bedside ultrasound; if PVR is >100 mL, perform intermittent sterile catheterization (avoid chronic indwelling urinary catheters due to infection risks).

3. THE DIAGNOSTIC GRID (Differential Diagnosis & Workup)

Top "Can't-Miss" Differential Diagnoses (MS Mimics)

1. Acute Ischemic or Hemorrhagic Stroke: Presents with sudden-onset unilateral weakness or sensory loss. Differentiated from MS by hyperacute onset (seconds to minutes) and classic arterial territory boundaries.
2. Neuromyelitis Optica (NMO / Devic Disease): A devastating demyelinating mimic that typically presents as bilateral optic neuritis or complete transverse myelopathy spanning three or more contiguous spinal segments.
3. Myasthenia Gravis: Presents with fluctuating, fatigable ptosis, diplopia, and bulbar weakness. Differentiated from MS by the complete sparing of sensation, coordination, and deep tendon reflexes.
4. Spinal Cord Compression (Epidural Abscess / Mass / Hematoma): Presents with localized spine pain, progressive paraplegia, and autonomic bowel/bladder dysfunction. Requires emergent MRI and neurosurgical decompression.
5. CNS Infections (Meningitis / Encephalitis): Presents with altered mental status, fever, headache, and meningismus. MS flares are typically afebrile unless precipitated by a secondary systemic infection.

Prioritized Diagnostic Workup Strategy

• Point-of-Care Capillary Glucose: Checked immediately on arrival to rule out hypoglycemia as a stroke and encephalopathy mimic.
• Screening Laboratory Panel: Complete blood count (CBC) to screen for occult infection; comprehensive metabolic panel (BMP) to exclude metabolic weakness mimics; creatine kinase and inflammatory markers (ESR/CRP).
• Urinalysis with Reflex Culture: Checked on every patient; urinary tract infections (UTIs) are the single most common precipitant of pseudo-relapses.
• Cerebrospinal Fluid (CSF) Analysis: No longer strictly required for diagnosing classic MS, but is crucial if a CNS infection is suspected (fever, neck stiffness, encephalopathy). Classic MS CSF findings include normal or slightly elevated WBC counts (<25 mononuclear cells/mm³), mildly elevated protein, elevated myelin basic protein, and the presence of oligoclonal bands.
• Neuroimaging (MRI): Symmetrical, gadolinium-enhanced MRI of the Brain and Spinal Cord is the gold standard. Non-contrast head CT is insensitive for demyelinating plaques but is used to rapidly exclude acute hemorrhage, trauma, or massive structural lesions.

4. THE VISUAL BOARD (ECG / POCUS / Imaging)

Electrocardiography (ECG) Checklist

• Check for conduction delays, QT prolongation, or new-onset bradyarrhythmias, which are critical to document prior to the outpatient initiation of sphingosine-1-phosphate receptor modulator disease-modifying therapies (DMTs) or in patients experiencing severe autonomic dysregulation.

Point-of-Care Ultrasound (POCUS) Checklist

• Perform a transabdominal bladder scan to calculate the post-void residual (PVR) volume. Ensure PVR is <100 mL to rule out subclinical neurogenic urinary retention, which can propagate ascending pyelonephritis.

Magnetic Resonance Imaging (MRI) Diagnostic Checklist

• T2/FLAIR Hyperintensities: Look for classically oval-shaped, discrete white matter lesions that appear bright on T2 and Fluid-Attenuated Inversion Recovery (FLAIR) sequences.
• Anatomical Predilections: Foci are classically located in the periventricular white matter, perpendicular to the ventricles / ependymal surface (representing perivenular inflammation, known as Dawson's fingers). Other key sites include juxtacortical white matter, the brainstem, cerebellum, and the cervical/thoracic spinal cord.
• Active Lesions: Demonstrate diffuse or ring-like enhancement on T1-weighted images with gadolinium contrast.
• The "MIMICS" Mnemonic (MRI Red Flags Atypical for MS):
• Meningeal enhancement
• Indistinct or rapidly increasing lesions
• Macrobleeds or microbleeds
• Infarcts
• Cavities or complete ring enhancement
• Symmetric lesions / sparing of U-fibers / spinal lesions involving \(\ge\) 3 segments.

5. THE SCORING MATRIX (Risk Stratification & Guidelines)

The McDonald Diagnostic Criteria

• While not formally diagnosed within the acute ED turn, the resident must understand that MS requires the demonstration of demyelinating lesions disseminated in time (different dates of symptom onset) and space (lesions localized to different anatomical regions of the CNS).

Defining Relapse vs. Pseudo-Exacerbation (Risk Stratification)

The clinician must immediately risk-stratify the patient's presentation into one of two categories, as this dictates the need for high-dose immunotherapy:

1. True Acute Relapse/Exacerbation:

• Definition: Symmetrical or asymmetrical, subacute development of objective neurological deficits lasting at least 24 hours (typically peaking at 1 week and resolving over weeks to months).
• Requirement: Occurs in the absence of fever, infection, or metabolic stressors.

1. Pseudo-Relapse/Pseudo-Exacerbation:

• Definition: A temporary, transient worsening of previously documented, old neurological deficits.
• Trigger: Precipitated by fever, minor core temperature elevations (Uhthoff phenomenon), active infections (classically UTIs), metabolic derangements, or physical exhaustion.
• Action: Steroids are not indicated; management must focus entirely on treating the underlying trigger.

6. THE DANGER ZONE (Pitfalls & Critical Actions)

Deadly Cognitive Traps & Trainee Pitfalls

• The "Exacerbation" Anchoring Trap (Steroids for Sepsis): Trainees frequently anchor on MS symptoms as an acute relapse and empirically initiate high-dose methylprednisolone without checking a urinalysis or temperature. Giving immunosuppressive megadose steroids to a patient whose deficits are actually a pseudo-flare triggered by an occult UTI or early urosepsis can lead to rapid bacteremia and septic shock.
• The Succinylcholine Hyperkalemia Pitfall: Administering succinylcholine during RSI to an MS patient presenting with acute respiratory distress and severe muscle wasting or chronic paraplegia. The massive upregulation of extrajunctional acetylcholine receptors in denervated muscle can trigger a fatal hyperkalemic cardiac arrest.
• Misinterpreting Normal CT Scans as "No Pathology": Discharging an acutely weak patient with suspected demyelinating disease because their head CT is normal. CT scan is completely insensitive for MS plaques; patients with new, progressive objective deficits must be admitted for MRI.
• Missing Silent Aspiration in Bulbar Exacerbations: Underestimating the aspiration risk in a patient presenting with an MS flare. Subtle dysarthria or dysphagia indicates medullary/bulbar involvement; failing to evaluate their swallowing mechanics prior to oral medication administration is a critical error.

Mandated Board-Exam Critical Actions

• Check and document a fingerstick capillary glucose immediately upon arrival.
• Perform and document a meticulous, detailed neurological exam (including gait and cranial nerves).
• Perform a bedside bladder scan to calculate post-void residual in any patient with lower extremity weakness or urinary complaints.
• Obtain a urinalysis to rule out UTI as a pseudo-relapse trigger before administering steroids.
• Formally assess and document suicide risk in any patient presenting with an acute exacerbation.

7. MCQ MASTERCLASS (Written Exam Tips)

High-Yield Exam "Buzzwords" and Associations

• "Uhthoff's Phenomenon": Reversible worsening of vision or neurological deficits triggered by increased body temperature, hot baths, or exercise.
• "Lhermitte's Phenomenon": An electric shock-like sensation radiating down the spine and into the limbs upon neck flexion; highly associated with cervical cord lesions.
• "Dawson's Fingers": The pathognomonic MRI description of demyelinating plaques perpendicular to the ependymal surface of the lateral ventricles.
• "Internuclear Ophthalmoplegia (INO)": A lesion of the medial longitudinal fasciculus (MLF). On lateral gaze, there is an inability to adduct the ipsilateral eye with nystagmus of the contralateral abducting eye. Preserved convergence confirms the lesion is brainstem-localized.
• "CSF Oligoclonal Bands": Present in up to 90% of confirmed MS cases; classically paired on exam questions with a normal WBC count or mild mononuclear pleocytosis, elevated myelin basic protein, and increased total IgG.

Differentiating Distractors

• Distractor: Initiating interferon-beta, fingolimod, or natalizumab in the ED.
• Correction: These are disease-modifying therapies (DMTs) used for chronic maintenance and are strictly managed in the outpatient setting by a neurologist; the ED only administers steroids for acute relapses.
• Distractor: Recommending an urgent lumbar puncture to diagnose a suspected MS flare.
• Correction: LP is no longer required for the routine diagnosis of MS; it should be reserved in the ED only if CNS infection must be ruled out.

8. THE BOARDROOM SCRIPT (OSCE & Oral Board Tips)

Triage and Stabilization Script

• "This patient presents with acute-on-chronic neurological deficits and has a history of Multiple Sclerosis. Because patients with MS are at high risk for aspiration due to bulbar weakness, I will immediately assess the airway, check their ability to clear secretions, and measure a baseline Forced Vital Capacity or Negative Inspiratory Force if respiratory effort is compromised. I will place the patient on a cardiorespiratory monitor, establish intravenous access, obtain an immediate capillary blood glucose to rule out hypoglycemia, and document a core temperature to screen for hyperthermia."

Mandatory Physical Exam Phrasing

• "I will perform a meticulous, comprehensive neurological and ocular examination. I will explicitly test cranial nerves, documenting the presence or absence of an afferent pupillary defect, internuclear ophthalmoplegia, or facial paresis. I will perform a complete motor and sensory exam, testing for upper motor neuron signs such as hyperreflexia, clonus, and Babinski's sign. I will check for Lhermitte's sign, assess cerebellar function, perform a gait assessment if safe, and obtain a bedside bladder ultrasound to screen for neurogenic urinary retention."

Diagnostics and Management Phrasing

• "Because the patient's airway is secure, I will order a targeted laboratory panel, including a CBC to screen for infection, a metabolic panel, and an ECG to check for conduction abnormalities. I will prioritize a urinalysis, as a UTI is the most common cause of pseudo-relapse in this population. If the patient has a fever or signs of infection, I will treat the underlying cause to restore normothermia and avoid administering immunosuppressive steroids. If I confirm a true acute MS relapse, I will consult neurology and administer high-dose Methylprednisolone, either as 1,000 mg intravenously or orally. I will perform a formal suicide risk assessment."

Disposition Phrasing

• "I will consult neurology. If the patient exhibits bulbar dysfunction, respiratory distress, severe motor weakness, or is unable to ambulate or care for themselves safely, I will admit them to a monitored neurology unit. If the symptoms represent a pseudo-exacerbation, the underlying infectious or metabolic trigger has been treated, and the patient has returned to their neurologic baseline with a safe ambulatory status and reliable social support, they can be safely discharged with outpatient neurology follow-up, clear steroid side-effect counseling, and strict return precautions."